[Hot Spots].

Guoxin Technology: The internal test of the new high-performance AI MCU chip was successful

Guoxin Technology (688262) announced on the evening of November 24 that the new high-performance AI MCU chip CCR7002 developed by the company has been successfully tested in the company's internal test recently. The new chip product successfully developed this time is CCR7002 high-performance AI MCU chip jointly developed by the company and Guangdong StarFive Technology Co., Ltd.

Yuegui shares: At present, there are no businesses and customers related to solid-state batteries

Yuegui shares (000833) on the evening of November 24 issued an announcement on abnormal fluctuations in stock trading, and market rumors that the company's pyrite may be the front-end raw material for solid-state batteries. According to investigation, the company currently has no solid-state battery-related business and customers.

Hunan Gold: Concerned about media reports that more than 40 gold veins have been discovered in Pingjiang

Hunan Gold (002155) issued an announcement on the evening of November 24 on abnormal fluctuations in stock trading, and the company paid attention to the media release that "more than 40 gold veins have been discovered in Pingjiang, Hunan: prospective reserves exceed 1,000 tons, with a valuation of 600 billion yuan". It is understood that the "Wangu Gold Mine in Pingjiang County, Hunan" in the report includes 1 mining right and 3 prospecting rights owned by Hunan Jinjindong Mining Co., Ltd., a wholly-owned subsidiary of the company, 5 mining rights and 7 prospecting rights owned by Hunan Gold Tianyue Mining Co., Ltd., a holding subsidiary of Hunan Gold Group Co., Ltd., the controlling shareholder, as well as surrounding prospecting rights owned by other private entities and blank areas that have not been demarcated. At present, the company and the controlling shareholder are actively promoting the project, and the gold resources that can finally be injected into the listed company are subject to the reserves submitted to the Hunan Provincial Department of Natural Resources for review and filing by the "integrated exploration" project in the Wangu mining area.

[Repurchase].

Shenlian Biological: The chairman proposed 20 million yuan to 40 million yuan to repurchase the company's shares

Shenlian Biotechnology (688098) announced on the evening of November 24 that Nie Dongsheng, one of the actual controllers and chairman of the company, proposed to repurchase the company's shares for 20 million yuan - 40 million yuan, and the repurchased shares are intended to be used for the implementation of employee stock ownership plans or equity incentives at an appropriate time in the future, or for the conversion of corporate bonds issued by listed companies that can be converted into shares.

[Contract Winning Bid].

China General Number: From September to October, it won the bid for ten important projects in the rail transit market

China General Number (688009) announced on the evening of November 24 that from September to October 2024, the company won the bid for a total of ten important projects in the rail transit market, including three in the railway market and seven in the urban rail transit market. The total amount of winning bids is approximately RMB3.107 billion, representing approximately 8.4% of the Company's audited operating revenue in 2023 under PRC accounting standards.

Maixinlin: The holding subsidiary signed two computing power service contracts

Maixinlin (688685) announced on the evening of November 24 that its holding subsidiary, Ruiying Intelligent Computing, signed a sales contract with Beijing Urban Construction, and Ruiying Intelligent Computing will provide basic computing services to Beijing Urban Construction, including computing resources and computing power networks. The contract amount is about 240 million yuan. Rockchip, a holding subsidiary, signed a sales contract with Beijing Urban Construction, under which Rockchip will provide basic computing services to Beijing Urban Construction, including computing resources and computing power networks. The contract amount is about 120 million yuan.

NXT: The holding subsidiary signed the "Global Strategic Cooperation Framework Agreement" with EVE

On the evening 002812 of November 24, EVE announced that its holding subsidiary, Shanghai NXT, signed the "Global Strategic Cooperation Framework Agreement" with EVE Lithium Energy (300014) on November 22, and the two sides will carry out long-term and stable cooperation in product supply and technical exchanges, and EVE is expected to purchase no less than 3 billion square meters of battery separator from Shanghai NXT and its controlled affiliates in Southeast Asia, Europe and other markets from 2025 to 2031.

Zhongzi Technology: Received a fixed-point notice for the development of hydrogen energy from the new research institute

Zhongzi Technology (688737) announced on the evening of November 24 that it recently received a fixed-point notice for the development of three fuel cell engines from Chengdu Xinyan Hydrogen Energy Technology Co., Ltd. (hereinafter referred to as "Xinyan Hydrogen Energy"), and the company will become a catalyst designated development supplier for three fuel cell engines of Xinyan Hydrogen Energy.

Yusys Technology: Won the bid for the customs informatization update project of 73.5588 million yuan

Yusys Technology (300674) announced on the evening of November 24 that it had recently received the "Notice of Winning the Bid (Transaction)" issued by the Material and Equipment Procurement Center of the General Administration of Customs, which made it clear that the company won the bid for the customs informatization update - server equipment 01 package. The winning bid amount was 73.5588 million yuan.

[Change in equity].

Shenzhen Xinxing: It is planned to transfer 100% of the equity of Huizhou Xinxing for 80.4418 million yuan

Shenzhen Xinxing (603978) announced on the evening of November 24 that it intends to transfer 100% of the equity of its wholly-owned subsidiary, Xinxing Light Alloy Materials (Huizhou) Co., Ltd. (hereinafter referred to as "Huizhou Xinxing"), to Tailing Technology (Guangdong) Co., Ltd., with an equity transfer price of 80.4418 million yuan. After the completion of this transaction, it is expected to generate an investment income of approximately 15 million yuan.

Kingfa Technology: A wholly-owned subsidiary plans to increase its capital and expand its shares to introduce an external investor, Goldstone Fund

Kingfa Technology (600143) announced on the evening of November 24 that its wholly-owned subsidiary, Special Plastics Company, intends to introduce external investors through capital increase and share expansion Jinshi Manufacturing Transformation and Upgrading New Materials Fund (Limited Partnership) (hereinafter referred to as "Goldstone Fund"), and Goldstone Fund intends to subscribe for the new registered capital of 19,164,431 yuan per 1 yuan of registered capital of 19,164,431 yuan, with a subscription consideration of 500 million yuan. Shanghai Kingfa, a wholly-owned subsidiary of the company, holds 100% of the equity of the company, and intends to give up its preemptive right to subscribe to the company in this capital increase, and after the completion of the capital increase, the company is still the company's holding subsidiary.

[M&A and reorganization].

Bangyan Technology: Suspension of trading in the planned purchase of a controlling stake in Xingwang Information and Communications

Bangyan Technology (688132) announced on the evening of November 24 that the company is planning to purchase a controlling stake in Shenzhen Xingwang Information and Communication Technology Co., Ltd. (hereinafter referred to as "Xingwang Information and Communication") by issuing shares and paying cash, and at the same time raise matching funds. Trading in the company's shares will be suspended from the market open on November 25, 2024 (Monday), and the suspension is expected to last no more than 5 trading days.

Nanjing Business Travel: It is planned to purchase 100% of the shares of Huangpu Hotel and resume trading

Nanjing Business Travel (600250) announced on the evening of November 24 that the company intends to purchase 100% of the equity of Huangpu Hotel held by the tourism group by issuing shares and paying cash and raise matching funds, with a transaction price of 222 million yuan (excluding the amount of matching funds raised). Trading in the Company's shares will resume from the market open on Monday, November 25, 2024.

[Other].

Highpower Technology: Elong Power, a subsidiary of Elong Power, was listed on NASDAQ

Highpower Technology (001283) announced on the evening of November 24 that the company invested in Elong Power Holding Limited (hereinafter referred to as "Elong Power") through its wholly-owned subsidiary, Huizhou Highpower Technology Co., Ltd., and indirectly held 1,727,200 shares of Elong Power. Recently, the company learned that Elong Power will be listed on the NASDAQ stock exchange in the United States on November 22, 2024 local time in the United States, with the stock code "ELPW".

Sanyou Medical: Ultrasound surgical equipment obtained medical device registration certificate

Sanyou Medical (688085) announced on the evening of November 24 that Beijing Shuimu Tianpeng Medical Equipment Co., Ltd., a wholly-owned subsidiary of Beijing Shuimu Tianpeng Medical Technology Co., Ltd., a holding subsidiary, recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the State Drug Administration for "ultrasound surgical equipment". The product is used in medical institutions, and the host is equipped with different handles and disposable cutter heads to achieve different clinical uses, including: ultrasonic cutting, grinding and drilling of bone tissue; Crushing, flushing and aspiration of brain tissue, liver tissue, kidney tissue and fallopian tubes, etc.

China Resources Shuanghe: Semaglutide Injection Drug Clinical Trial Approved

China Resources Shuanghe (600062) announced on the evening of November 24 that it received the "Drug Clinical Trial Approval Notice" for semaglutide injection issued by the State Food and Drug Administration.

Aojing Medical: A wholly-owned subsidiary of Absorbable Collagen Hemostatic Sponge obtained the medical device registration certificate

Aojing Medical (688613) announced on the evening of November 24 that its wholly-owned subsidiary, Aojing Devices, received the "Medical Device Registration Certificate" for absorbable collagen hemostatic sponge issued by the State Food and Drug Administration, which is suitable for hemostasis in the surgical process (except ophthalmology, urology, neurosurgery), and can be used for hemostasis of capillary, venulous and arteriolar bleeding when pressure, ligation or other traditional hemostasis methods are ineffective, and is widely used in various types of medical places.